Drug Trial Radar · NCT00151489
Safety and Efficacy Study of Pregabalin in Fibromyalgia
Last checked: Nov 20, 2026Latest source record: Jan 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,020
Actual
Start
Apr 2005
Primary completion
Not stated
Study completion Jun 2006
Sponsor
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Pfizer (PFE)
- Sponsor type
- Industry
- First posted
- Sep 9, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if different dosages work better (reduce pain and mild to no side effects) for different people.
Conditions
- Fibromyalgia
Interventions
pregabalinDrug
placeboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of pregabalin (BID) compared with placebo in assessing the durability of effect for the treatment of pain associated with fibromyalgia among patients who initially respond to open-label pregabalin using Pain Visual Analog Scale
Locations
109 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Anniston, Alabama
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Calera, Alabama
Pfizer Investigational Site
Huntsville, Alabama
Pfizer Investigational Site
Tuscaloosa, Alabama
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Scottsdale, Arizona
Pfizer Investigational Site
Fayetteville, Arkansas
Pfizer Investigational Site
Hot Springs, Arkansas
Pfizer Investigational Site
Anaheim, California
Pfizer Investigational Site
Carmichael, California
Pfizer Investigational Site
Fresno, California
Pfizer Investigational Site
Los Alamitos, California
Pfizer Investigational Site
Northridge, California
Pfizer Investigational Site
Pismo Beach, California
Pfizer Investigational Site
Santa Ana, California
Pfizer Investigational Site
Walnut Creek, California
Pfizer Investigational Site
Whittier, California
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Stratford, Connecticut
Pfizer Investigational Site
Newark, Delaware
Pfizer Investigational Site
Washington D.C., District of Columbia
Pfizer Investigational Site
Chiefland, Florida
Pfizer Investigational Site
Clearwater, Florida
Pfizer Investigational Site
Kissimmee, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Palm Harbor, Florida
Pfizer Investigational Site
Palm Springs, Florida
Pfizer Investigational Site
Plantation, Florida
Pfizer Investigational Site
Plantation, Florida
Pfizer Investigational Site
St. Petersburg, Florida
Pfizer Investigational Site
Sunrise, Florida
Pfizer Investigational Site
Tampa, Florida
Pfizer Investigational Site
West Palm Beach, Florida
Pfizer Investigational Site
Atlanta, Georgia
Pfizer Investigational Site
Gurnee, Illinois
Pfizer Investigational Site
Peoria, Illinois
Showing 40 of 109 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.